Johanna Holmgren
Malmoe, M, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Risk of Infection Before and After Thiopurine Therapy in Inflammatory Bowel Disease: A Population-Based Study.
Journal: Journal of clinical gastroenterology
Published: September 17, 2025
Chronic mesenteric ischemia diagnosed via incidental CT findings with gastroenterologist perspective: Two case reports.
Journal: World journal of gastrointestinal pathophysiology
Published: August 07, 2025
Dietary index based on the Food Standards Agency nutrient profiling system and risk of Crohn's disease and ulcerative colitis.
Journal: Alimentary pharmacology & therapeutics
Published: August 27, 2023
Letter: to switch or not to switch, that is the question-author's reply.
Journal: Alimentary pharmacology & therapeutics
Published: August 08, 2022
Editorial: intravenous to subcutaneous vedolizumab-switch without glitch! Authors' reply.
Journal: Alimentary pharmacology & therapeutics
Published: June 24, 2022
Real-world data on switching from intravenous to subcutaneous vedolizumab treatment in patients with inflammatory bowel disease.
Journal: Alimentary pharmacology & therapeutics
Published: February 24, 2022
The Risk of Serious Infections Before and After Anti-TNF Therapy in Inflammatory Bowel Disease: A Retrospective Cohort Study.
Journal: Inflammatory bowel diseases
Published: December 29, 2021
Adult-onset inflammatory bowel disease and rate of serious infections compared to the general population: a nationwide register-based cohort study 2002-2017.
Journal: Scandinavian journal of gastroenterology
Published: August 09, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026